Literature DB >> 18273764

[Good practice of secondary data analysis, first revision].

.   

Abstract

After publication of the "Good Practice Secondary Data Analysis" (GPS) in 2005, the scientific use of secondary data has further increased. Based on several feedbacks to the first version of this guideline, the Working Group "Collection and Use of Secondary Data" (AGENS) of the German Society of Social Medicine and Prevention (DGSMP) together with the working group 'Epidemiological Methods' of the German Society of Epidemiology (DGEpi), the German Society for Medical Informatics, Biometrics and Epidemiology (GMDS) and the German Society of Social Medicine and Prevention (DGSMP) undertook the first revision of the GPS, which will be implemented in the beginning of 2008. The second version of the GPS was restructured in relation to the first version. Now, the numbering of the guidelines is the same as that of the Good Epidemiological Practice (GEP). The GPS guidelines also have the same wording as in the GEP. The specific conditions and requirements of secondary data analysis were addressed in the explanations of the guidelines and their recommendations. The glossary at the end of the GPS was extended. In the last three years the GPS has become established as a standard for secondary data analyses. Additionally, the GPS may be used as a basis for contractual arrangements between data owners and researchers. This version of the GPS is valid to the end of 2010.

Entities:  

Mesh:

Year:  2008        PMID: 18273764     DOI: 10.1055/s-2007-1022529

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  29 in total

1.  [Health services research in oncology using claims data].

Authors:  Falk Hoffmann; Gerd Glaeske
Journal:  Med Klin (Munich)       Date:  2010-06-26

2.  In reply.

Authors:  Johannes Hauswaldt; Eva Hummers-Pradier; Ulrike Junius-Walker
Journal:  Dtsch Arztebl Int       Date:  2013-04       Impact factor: 5.594

3.  Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany.

Authors:  Bernadette Pöllinger; Wolfgang Schmidt; Anna Seiffert; Heidi Imhoff; Martin Emmert
Journal:  Eur J Health Econ       Date:  2018-01-23

4.  Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data.

Authors:  Ingrid Schubert; Peter Ihle; Rainer Sabatowski
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

5.  Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Authors:  Heiner Claessen; Jutta Genz; Bernd Bertram; Christoph Trautner; Guido Giani; Iris Zöllner; Andrea Icks
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

6.  Early discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysis.

Authors:  Helmut Anderten; Franz-Werner Dippel; Karel Kostev
Journal:  J Diabetes Sci Technol       Date:  2015-01-07

7.  Health service use among patients with chronic or multiple illnesses, and frequent attenders: secondary analysis of routine primary care data from 1996 to 2006.

Authors:  Johannes Hauswaldt; Eva Hummers-Pradier; Ulrike Junius-Walker
Journal:  Dtsch Arztebl Int       Date:  2012-11-23       Impact factor: 5.594

8.  A pilot study on the effects of a team building process on the perception of work environment in an integrative hospital for neurological rehabilitation.

Authors:  Thomas Ostermann; Mathias Bertram; Arndt Büssing
Journal:  BMC Complement Altern Med       Date:  2010-03-09       Impact factor: 3.659

9.  Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany.

Authors:  Andrea Icks; Heiner Claessen; Stephan Morbach; Gerd Glaeske; Falk Hoffmann
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

10.  Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Fam Pract       Date:  2009-12-10       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.